AGING DIS 润色咨询

Aging and Disease

出版年份：暂无数据 年文章数：783 投稿命中率： 开通期刊会员，数据随心看

出版周期：Bimonthly 自引率：11.0% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2195631, encodeId=d33f2195631a6, content=影响因子和aging cell 一样，nature aging拒了后来这的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Wed Mar 27 11:14:02 CST 2024, time=2024-03-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192927, encodeId=cc8f219292e60, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：12.18投稿 1.9号一审结束，审稿人态度良好，给的意见也比较温和，需要大修 2.29号修回 3.1 awaiting reviewer score 3.10 awaiting eic decision 现在一直没消息！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5ca8184855, createdName=ms6000000187674201, createdTime=Wed Mar 13 10:43:00 CST 2024, time=2024-03-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1234286, encodeId=d9b3123428608, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：转化医学;心血管<br>经验分享：2月11日提交的 3月15日外审结束给了大修 4月14日返修之后4月17日给的接收 杂志效率很高，主编非常nice，版面费3000美金比较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff425709648, createdName=ms4000001964182854, createdTime=Sat Jul 23 19:22:09 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187382, encodeId=fe96218e38223, content=偏重的研究方向：脑血管病<br>经验分享：请问这个杂志是水刊吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08f22302355, createdName=Trr, createdTime=Thu Feb 15 10:39:17 CST 2024, time=2024-02-15, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2184662, encodeId=4b2b2184662a6, content=等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c77d5494646, createdName=ms7000000657762546, createdTime=Mon Jan 29 16:45:47 CST 2024, time=2024-01-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183667, encodeId=2033218366e2e, content=123, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4f48543542, createdName=ms5000000381647453, createdTime=Wed Jan 24 13:17:17 CST 2024, time=2024-01-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1212566, encodeId=91ff121256625, content=投稿第二天awaiting AE final processing,要哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12c68124177, createdName=ms4000000135134794, createdTime=Tue Apr 19 15:56:10 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2179193, encodeId=70a721e91938e, content=还没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c816424366, createdName=ms9000001971480048, createdTime=Thu Jan 04 10:52:58 CST 2024, time=2024-01-04, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1081652, encodeId=fdcd10816527f, content=awaiting reviewer assignment 了6天进入awaiting reviewer scores，这种情况是要拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKEcicZP30abw0lwY6ial6Fp8WPXJJY8QlTMHKpvGZhlBWUNGZiaVPhjibtw3VOxEwcCVGD9LZqy5Y4fA/132, createdBy=aaa55205975, createdName=zhaowujun567, createdTime=Sat Dec 18 22:39:46 CST 2021, time=2021-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188525, encodeId=dbce1188525b5, content=Awaiting AE Final Processing 这个状态一定会有马, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=44735423416, createdName=ms8000001716353498, createdTime=Thu Jan 27 09:28:05 CST 2022, time=2022-01-27, status=1, ipAttribution=)]
    2024-03-27 osmataku 来自北京

    影响因子和aging cell 一样，nature aging拒了后来这的

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2195631, encodeId=d33f2195631a6, content=影响因子和aging cell 一样，nature aging拒了后来这的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Wed Mar 27 11:14:02 CST 2024, time=2024-03-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192927, encodeId=cc8f219292e60, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：12.18投稿 1.9号一审结束，审稿人态度良好，给的意见也比较温和，需要大修 2.29号修回 3.1 awaiting reviewer score 3.10 awaiting eic decision 现在一直没消息！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5ca8184855, createdName=ms6000000187674201, createdTime=Wed Mar 13 10:43:00 CST 2024, time=2024-03-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1234286, encodeId=d9b3123428608, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：转化医学;心血管<br>经验分享：2月11日提交的 3月15日外审结束给了大修 4月14日返修之后4月17日给的接收 杂志效率很高，主编非常nice，版面费3000美金比较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff425709648, createdName=ms4000001964182854, createdTime=Sat Jul 23 19:22:09 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187382, encodeId=fe96218e38223, content=偏重的研究方向：脑血管病<br>经验分享：请问这个杂志是水刊吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08f22302355, createdName=Trr, createdTime=Thu Feb 15 10:39:17 CST 2024, time=2024-02-15, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2184662, encodeId=4b2b2184662a6, content=等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c77d5494646, createdName=ms7000000657762546, createdTime=Mon Jan 29 16:45:47 CST 2024, time=2024-01-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183667, encodeId=2033218366e2e, content=123, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4f48543542, createdName=ms5000000381647453, createdTime=Wed Jan 24 13:17:17 CST 2024, time=2024-01-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1212566, encodeId=91ff121256625, content=投稿第二天awaiting AE final processing,要哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12c68124177, createdName=ms4000000135134794, createdTime=Tue Apr 19 15:56:10 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2179193, encodeId=70a721e91938e, content=还没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c816424366, createdName=ms9000001971480048, createdTime=Thu Jan 04 10:52:58 CST 2024, time=2024-01-04, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1081652, encodeId=fdcd10816527f, content=awaiting reviewer assignment 了6天进入awaiting reviewer scores，这种情况是要拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKEcicZP30abw0lwY6ial6Fp8WPXJJY8QlTMHKpvGZhlBWUNGZiaVPhjibtw3VOxEwcCVGD9LZqy5Y4fA/132, createdBy=aaa55205975, createdName=zhaowujun567, createdTime=Sat Dec 18 22:39:46 CST 2021, time=2021-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188525, encodeId=dbce1188525b5, content=Awaiting AE Final Processing 这个状态一定会有马, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=44735423416, createdName=ms8000001716353498, createdTime=Thu Jan 27 09:28:05 CST 2022, time=2022-01-27, status=1, ipAttribution=)]
    2024-03-13 ms6000000187674201 来自上海

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享：12.18投稿 1.9号一审结束，审稿人态度良好，给的意见也比较温和，需要大修 2.29号修回 3.1 awaiting reviewer score 3.10 awaiting eic decision 现在一直没消息！

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2195631, encodeId=d33f2195631a6, content=影响因子和aging cell 一样，nature aging拒了后来这的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Wed Mar 27 11:14:02 CST 2024, time=2024-03-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192927, encodeId=cc8f219292e60, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：12.18投稿 1.9号一审结束，审稿人态度良好，给的意见也比较温和，需要大修 2.29号修回 3.1 awaiting reviewer score 3.10 awaiting eic decision 现在一直没消息！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5ca8184855, createdName=ms6000000187674201, createdTime=Wed Mar 13 10:43:00 CST 2024, time=2024-03-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1234286, encodeId=d9b3123428608, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：转化医学;心血管<br>经验分享：2月11日提交的 3月15日外审结束给了大修 4月14日返修之后4月17日给的接收 杂志效率很高，主编非常nice，版面费3000美金比较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff425709648, createdName=ms4000001964182854, createdTime=Sat Jul 23 19:22:09 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187382, encodeId=fe96218e38223, content=偏重的研究方向：脑血管病<br>经验分享：请问这个杂志是水刊吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08f22302355, createdName=Trr, createdTime=Thu Feb 15 10:39:17 CST 2024, time=2024-02-15, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2184662, encodeId=4b2b2184662a6, content=等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c77d5494646, createdName=ms7000000657762546, createdTime=Mon Jan 29 16:45:47 CST 2024, time=2024-01-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183667, encodeId=2033218366e2e, content=123, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4f48543542, createdName=ms5000000381647453, createdTime=Wed Jan 24 13:17:17 CST 2024, time=2024-01-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1212566, encodeId=91ff121256625, content=投稿第二天awaiting AE final processing,要哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12c68124177, createdName=ms4000000135134794, createdTime=Tue Apr 19 15:56:10 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2179193, encodeId=70a721e91938e, content=还没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c816424366, createdName=ms9000001971480048, createdTime=Thu Jan 04 10:52:58 CST 2024, time=2024-01-04, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1081652, encodeId=fdcd10816527f, content=awaiting reviewer assignment 了6天进入awaiting reviewer scores，这种情况是要拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKEcicZP30abw0lwY6ial6Fp8WPXJJY8QlTMHKpvGZhlBWUNGZiaVPhjibtw3VOxEwcCVGD9LZqy5Y4fA/132, createdBy=aaa55205975, createdName=zhaowujun567, createdTime=Sat Dec 18 22:39:46 CST 2021, time=2021-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188525, encodeId=dbce1188525b5, content=Awaiting AE Final Processing 这个状态一定会有马, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=44735423416, createdName=ms8000001716353498, createdTime=Thu Jan 27 09:28:05 CST 2022, time=2022-01-27, status=1, ipAttribution=)]
    2022-07-23 ms4000001964182854

    审稿速度:3.0 | 投稿命中率:50.0
    偏重的研究方向：转化医学;心血管
    经验分享：2月11日提交的 3月15日外审结束给了大修 4月14日返修之后4月17日给的接收 杂志效率很高，主编非常nice，版面费3000美金比较高

    6

    展开6条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2195631, encodeId=d33f2195631a6, content=影响因子和aging cell 一样，nature aging拒了后来这的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Wed Mar 27 11:14:02 CST 2024, time=2024-03-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192927, encodeId=cc8f219292e60, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：12.18投稿 1.9号一审结束，审稿人态度良好，给的意见也比较温和，需要大修 2.29号修回 3.1 awaiting reviewer score 3.10 awaiting eic decision 现在一直没消息！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5ca8184855, createdName=ms6000000187674201, createdTime=Wed Mar 13 10:43:00 CST 2024, time=2024-03-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1234286, encodeId=d9b3123428608, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：转化医学;心血管<br>经验分享：2月11日提交的 3月15日外审结束给了大修 4月14日返修之后4月17日给的接收 杂志效率很高，主编非常nice，版面费3000美金比较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff425709648, createdName=ms4000001964182854, createdTime=Sat Jul 23 19:22:09 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187382, encodeId=fe96218e38223, content=偏重的研究方向：脑血管病<br>经验分享：请问这个杂志是水刊吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08f22302355, createdName=Trr, createdTime=Thu Feb 15 10:39:17 CST 2024, time=2024-02-15, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2184662, encodeId=4b2b2184662a6, content=等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c77d5494646, createdName=ms7000000657762546, createdTime=Mon Jan 29 16:45:47 CST 2024, time=2024-01-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183667, encodeId=2033218366e2e, content=123, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4f48543542, createdName=ms5000000381647453, createdTime=Wed Jan 24 13:17:17 CST 2024, time=2024-01-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1212566, encodeId=91ff121256625, content=投稿第二天awaiting AE final processing,要哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12c68124177, createdName=ms4000000135134794, createdTime=Tue Apr 19 15:56:10 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2179193, encodeId=70a721e91938e, content=还没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c816424366, createdName=ms9000001971480048, createdTime=Thu Jan 04 10:52:58 CST 2024, time=2024-01-04, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1081652, encodeId=fdcd10816527f, content=awaiting reviewer assignment 了6天进入awaiting reviewer scores，这种情况是要拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKEcicZP30abw0lwY6ial6Fp8WPXJJY8QlTMHKpvGZhlBWUNGZiaVPhjibtw3VOxEwcCVGD9LZqy5Y4fA/132, createdBy=aaa55205975, createdName=zhaowujun567, createdTime=Sat Dec 18 22:39:46 CST 2021, time=2021-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188525, encodeId=dbce1188525b5, content=Awaiting AE Final Processing 这个状态一定会有马, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=44735423416, createdName=ms8000001716353498, createdTime=Thu Jan 27 09:28:05 CST 2022, time=2022-01-27, status=1, ipAttribution=)]
    2024-02-15 Trr 来自安徽省

    偏重的研究方向：脑血管病
    经验分享：请问这个杂志是水刊吗？

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2195631, encodeId=d33f2195631a6, content=影响因子和aging cell 一样，nature aging拒了后来这的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Wed Mar 27 11:14:02 CST 2024, time=2024-03-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192927, encodeId=cc8f219292e60, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：12.18投稿 1.9号一审结束，审稿人态度良好，给的意见也比较温和，需要大修 2.29号修回 3.1 awaiting reviewer score 3.10 awaiting eic decision 现在一直没消息！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5ca8184855, createdName=ms6000000187674201, createdTime=Wed Mar 13 10:43:00 CST 2024, time=2024-03-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1234286, encodeId=d9b3123428608, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：转化医学;心血管<br>经验分享：2月11日提交的 3月15日外审结束给了大修 4月14日返修之后4月17日给的接收 杂志效率很高，主编非常nice，版面费3000美金比较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff425709648, createdName=ms4000001964182854, createdTime=Sat Jul 23 19:22:09 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187382, encodeId=fe96218e38223, content=偏重的研究方向：脑血管病<br>经验分享：请问这个杂志是水刊吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08f22302355, createdName=Trr, createdTime=Thu Feb 15 10:39:17 CST 2024, time=2024-02-15, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2184662, encodeId=4b2b2184662a6, content=等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c77d5494646, createdName=ms7000000657762546, createdTime=Mon Jan 29 16:45:47 CST 2024, time=2024-01-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183667, encodeId=2033218366e2e, content=123, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4f48543542, createdName=ms5000000381647453, createdTime=Wed Jan 24 13:17:17 CST 2024, time=2024-01-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1212566, encodeId=91ff121256625, content=投稿第二天awaiting AE final processing,要哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12c68124177, createdName=ms4000000135134794, createdTime=Tue Apr 19 15:56:10 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2179193, encodeId=70a721e91938e, content=还没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c816424366, createdName=ms9000001971480048, createdTime=Thu Jan 04 10:52:58 CST 2024, time=2024-01-04, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1081652, encodeId=fdcd10816527f, content=awaiting reviewer assignment 了6天进入awaiting reviewer scores，这种情况是要拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKEcicZP30abw0lwY6ial6Fp8WPXJJY8QlTMHKpvGZhlBWUNGZiaVPhjibtw3VOxEwcCVGD9LZqy5Y4fA/132, createdBy=aaa55205975, createdName=zhaowujun567, createdTime=Sat Dec 18 22:39:46 CST 2021, time=2021-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188525, encodeId=dbce1188525b5, content=Awaiting AE Final Processing 这个状态一定会有马, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=44735423416, createdName=ms8000001716353498, createdTime=Thu Jan 27 09:28:05 CST 2022, time=2022-01-27, status=1, ipAttribution=)]
    2024-01-29 ms7000000657762546 来自北京

    等待

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2195631, encodeId=d33f2195631a6, content=影响因子和aging cell 一样，nature aging拒了后来这的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Wed Mar 27 11:14:02 CST 2024, time=2024-03-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192927, encodeId=cc8f219292e60, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：12.18投稿 1.9号一审结束，审稿人态度良好，给的意见也比较温和，需要大修 2.29号修回 3.1 awaiting reviewer score 3.10 awaiting eic decision 现在一直没消息！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5ca8184855, createdName=ms6000000187674201, createdTime=Wed Mar 13 10:43:00 CST 2024, time=2024-03-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1234286, encodeId=d9b3123428608, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：转化医学;心血管<br>经验分享：2月11日提交的 3月15日外审结束给了大修 4月14日返修之后4月17日给的接收 杂志效率很高，主编非常nice，版面费3000美金比较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff425709648, createdName=ms4000001964182854, createdTime=Sat Jul 23 19:22:09 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187382, encodeId=fe96218e38223, content=偏重的研究方向：脑血管病<br>经验分享：请问这个杂志是水刊吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08f22302355, createdName=Trr, createdTime=Thu Feb 15 10:39:17 CST 2024, time=2024-02-15, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2184662, encodeId=4b2b2184662a6, content=等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c77d5494646, createdName=ms7000000657762546, createdTime=Mon Jan 29 16:45:47 CST 2024, time=2024-01-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183667, encodeId=2033218366e2e, content=123, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4f48543542, createdName=ms5000000381647453, createdTime=Wed Jan 24 13:17:17 CST 2024, time=2024-01-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1212566, encodeId=91ff121256625, content=投稿第二天awaiting AE final processing,要哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12c68124177, createdName=ms4000000135134794, createdTime=Tue Apr 19 15:56:10 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2179193, encodeId=70a721e91938e, content=还没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c816424366, createdName=ms9000001971480048, createdTime=Thu Jan 04 10:52:58 CST 2024, time=2024-01-04, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1081652, encodeId=fdcd10816527f, content=awaiting reviewer assignment 了6天进入awaiting reviewer scores，这种情况是要拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKEcicZP30abw0lwY6ial6Fp8WPXJJY8QlTMHKpvGZhlBWUNGZiaVPhjibtw3VOxEwcCVGD9LZqy5Y4fA/132, createdBy=aaa55205975, createdName=zhaowujun567, createdTime=Sat Dec 18 22:39:46 CST 2021, time=2021-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188525, encodeId=dbce1188525b5, content=Awaiting AE Final Processing 这个状态一定会有马, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=44735423416, createdName=ms8000001716353498, createdTime=Thu Jan 27 09:28:05 CST 2022, time=2022-01-27, status=1, ipAttribution=)]
    2024-01-24 ms5000000381647453 来自四川省

    123

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2195631, encodeId=d33f2195631a6, content=影响因子和aging cell 一样，nature aging拒了后来这的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Wed Mar 27 11:14:02 CST 2024, time=2024-03-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192927, encodeId=cc8f219292e60, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：12.18投稿 1.9号一审结束，审稿人态度良好，给的意见也比较温和，需要大修 2.29号修回 3.1 awaiting reviewer score 3.10 awaiting eic decision 现在一直没消息！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5ca8184855, createdName=ms6000000187674201, createdTime=Wed Mar 13 10:43:00 CST 2024, time=2024-03-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1234286, encodeId=d9b3123428608, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：转化医学;心血管<br>经验分享：2月11日提交的 3月15日外审结束给了大修 4月14日返修之后4月17日给的接收 杂志效率很高，主编非常nice，版面费3000美金比较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff425709648, createdName=ms4000001964182854, createdTime=Sat Jul 23 19:22:09 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187382, encodeId=fe96218e38223, content=偏重的研究方向：脑血管病<br>经验分享：请问这个杂志是水刊吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08f22302355, createdName=Trr, createdTime=Thu Feb 15 10:39:17 CST 2024, time=2024-02-15, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2184662, encodeId=4b2b2184662a6, content=等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c77d5494646, createdName=ms7000000657762546, createdTime=Mon Jan 29 16:45:47 CST 2024, time=2024-01-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183667, encodeId=2033218366e2e, content=123, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4f48543542, createdName=ms5000000381647453, createdTime=Wed Jan 24 13:17:17 CST 2024, time=2024-01-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1212566, encodeId=91ff121256625, content=投稿第二天awaiting AE final processing,要哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12c68124177, createdName=ms4000000135134794, createdTime=Tue Apr 19 15:56:10 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2179193, encodeId=70a721e91938e, content=还没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c816424366, createdName=ms9000001971480048, createdTime=Thu Jan 04 10:52:58 CST 2024, time=2024-01-04, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1081652, encodeId=fdcd10816527f, content=awaiting reviewer assignment 了6天进入awaiting reviewer scores，这种情况是要拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKEcicZP30abw0lwY6ial6Fp8WPXJJY8QlTMHKpvGZhlBWUNGZiaVPhjibtw3VOxEwcCVGD9LZqy5Y4fA/132, createdBy=aaa55205975, createdName=zhaowujun567, createdTime=Sat Dec 18 22:39:46 CST 2021, time=2021-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188525, encodeId=dbce1188525b5, content=Awaiting AE Final Processing 这个状态一定会有马, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=44735423416, createdName=ms8000001716353498, createdTime=Thu Jan 27 09:28:05 CST 2022, time=2022-01-27, status=1, ipAttribution=)]
    2022-04-19 ms4000000135134794

    投稿第二天awaiting AE final processing,要哭了

    10

    展开10条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2195631, encodeId=d33f2195631a6, content=影响因子和aging cell 一样，nature aging拒了后来这的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Wed Mar 27 11:14:02 CST 2024, time=2024-03-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192927, encodeId=cc8f219292e60, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：12.18投稿 1.9号一审结束，审稿人态度良好，给的意见也比较温和，需要大修 2.29号修回 3.1 awaiting reviewer score 3.10 awaiting eic decision 现在一直没消息！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5ca8184855, createdName=ms6000000187674201, createdTime=Wed Mar 13 10:43:00 CST 2024, time=2024-03-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1234286, encodeId=d9b3123428608, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：转化医学;心血管<br>经验分享：2月11日提交的 3月15日外审结束给了大修 4月14日返修之后4月17日给的接收 杂志效率很高，主编非常nice，版面费3000美金比较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff425709648, createdName=ms4000001964182854, createdTime=Sat Jul 23 19:22:09 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187382, encodeId=fe96218e38223, content=偏重的研究方向：脑血管病<br>经验分享：请问这个杂志是水刊吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08f22302355, createdName=Trr, createdTime=Thu Feb 15 10:39:17 CST 2024, time=2024-02-15, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2184662, encodeId=4b2b2184662a6, content=等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c77d5494646, createdName=ms7000000657762546, createdTime=Mon Jan 29 16:45:47 CST 2024, time=2024-01-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183667, encodeId=2033218366e2e, content=123, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4f48543542, createdName=ms5000000381647453, createdTime=Wed Jan 24 13:17:17 CST 2024, time=2024-01-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1212566, encodeId=91ff121256625, content=投稿第二天awaiting AE final processing,要哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12c68124177, createdName=ms4000000135134794, createdTime=Tue Apr 19 15:56:10 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2179193, encodeId=70a721e91938e, content=还没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c816424366, createdName=ms9000001971480048, createdTime=Thu Jan 04 10:52:58 CST 2024, time=2024-01-04, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1081652, encodeId=fdcd10816527f, content=awaiting reviewer assignment 了6天进入awaiting reviewer scores，这种情况是要拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKEcicZP30abw0lwY6ial6Fp8WPXJJY8QlTMHKpvGZhlBWUNGZiaVPhjibtw3VOxEwcCVGD9LZqy5Y4fA/132, createdBy=aaa55205975, createdName=zhaowujun567, createdTime=Sat Dec 18 22:39:46 CST 2021, time=2021-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188525, encodeId=dbce1188525b5, content=Awaiting AE Final Processing 这个状态一定会有马, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=44735423416, createdName=ms8000001716353498, createdTime=Thu Jan 27 09:28:05 CST 2022, time=2022-01-27, status=1, ipAttribution=)]
    2024-01-04 ms9000001971480048 来自河北省

    还没投

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2195631, encodeId=d33f2195631a6, content=影响因子和aging cell 一样，nature aging拒了后来这的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Wed Mar 27 11:14:02 CST 2024, time=2024-03-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192927, encodeId=cc8f219292e60, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：12.18投稿 1.9号一审结束，审稿人态度良好，给的意见也比较温和，需要大修 2.29号修回 3.1 awaiting reviewer score 3.10 awaiting eic decision 现在一直没消息！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5ca8184855, createdName=ms6000000187674201, createdTime=Wed Mar 13 10:43:00 CST 2024, time=2024-03-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1234286, encodeId=d9b3123428608, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：转化医学;心血管<br>经验分享：2月11日提交的 3月15日外审结束给了大修 4月14日返修之后4月17日给的接收 杂志效率很高，主编非常nice，版面费3000美金比较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff425709648, createdName=ms4000001964182854, createdTime=Sat Jul 23 19:22:09 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187382, encodeId=fe96218e38223, content=偏重的研究方向：脑血管病<br>经验分享：请问这个杂志是水刊吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08f22302355, createdName=Trr, createdTime=Thu Feb 15 10:39:17 CST 2024, time=2024-02-15, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2184662, encodeId=4b2b2184662a6, content=等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c77d5494646, createdName=ms7000000657762546, createdTime=Mon Jan 29 16:45:47 CST 2024, time=2024-01-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183667, encodeId=2033218366e2e, content=123, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4f48543542, createdName=ms5000000381647453, createdTime=Wed Jan 24 13:17:17 CST 2024, time=2024-01-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1212566, encodeId=91ff121256625, content=投稿第二天awaiting AE final processing,要哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12c68124177, createdName=ms4000000135134794, createdTime=Tue Apr 19 15:56:10 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2179193, encodeId=70a721e91938e, content=还没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c816424366, createdName=ms9000001971480048, createdTime=Thu Jan 04 10:52:58 CST 2024, time=2024-01-04, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1081652, encodeId=fdcd10816527f, content=awaiting reviewer assignment 了6天进入awaiting reviewer scores，这种情况是要拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKEcicZP30abw0lwY6ial6Fp8WPXJJY8QlTMHKpvGZhlBWUNGZiaVPhjibtw3VOxEwcCVGD9LZqy5Y4fA/132, createdBy=aaa55205975, createdName=zhaowujun567, createdTime=Sat Dec 18 22:39:46 CST 2021, time=2021-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188525, encodeId=dbce1188525b5, content=Awaiting AE Final Processing 这个状态一定会有马, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=44735423416, createdName=ms8000001716353498, createdTime=Thu Jan 27 09:28:05 CST 2022, time=2022-01-27, status=1, ipAttribution=)]
    2021-12-18 zhaowujun567

    awaiting reviewer assignment 了6天进入awaiting reviewer scores，这种情况是要拒稿了吗

    9

    展开9条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2195631, encodeId=d33f2195631a6, content=影响因子和aging cell 一样，nature aging拒了后来这的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Wed Mar 27 11:14:02 CST 2024, time=2024-03-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192927, encodeId=cc8f219292e60, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：12.18投稿 1.9号一审结束，审稿人态度良好，给的意见也比较温和，需要大修 2.29号修回 3.1 awaiting reviewer score 3.10 awaiting eic decision 现在一直没消息！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5ca8184855, createdName=ms6000000187674201, createdTime=Wed Mar 13 10:43:00 CST 2024, time=2024-03-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1234286, encodeId=d9b3123428608, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：转化医学;心血管<br>经验分享：2月11日提交的 3月15日外审结束给了大修 4月14日返修之后4月17日给的接收 杂志效率很高，主编非常nice，版面费3000美金比较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff425709648, createdName=ms4000001964182854, createdTime=Sat Jul 23 19:22:09 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187382, encodeId=fe96218e38223, content=偏重的研究方向：脑血管病<br>经验分享：请问这个杂志是水刊吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08f22302355, createdName=Trr, createdTime=Thu Feb 15 10:39:17 CST 2024, time=2024-02-15, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2184662, encodeId=4b2b2184662a6, content=等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c77d5494646, createdName=ms7000000657762546, createdTime=Mon Jan 29 16:45:47 CST 2024, time=2024-01-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183667, encodeId=2033218366e2e, content=123, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4f48543542, createdName=ms5000000381647453, createdTime=Wed Jan 24 13:17:17 CST 2024, time=2024-01-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1212566, encodeId=91ff121256625, content=投稿第二天awaiting AE final processing,要哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12c68124177, createdName=ms4000000135134794, createdTime=Tue Apr 19 15:56:10 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2179193, encodeId=70a721e91938e, content=还没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c816424366, createdName=ms9000001971480048, createdTime=Thu Jan 04 10:52:58 CST 2024, time=2024-01-04, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1081652, encodeId=fdcd10816527f, content=awaiting reviewer assignment 了6天进入awaiting reviewer scores，这种情况是要拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKEcicZP30abw0lwY6ial6Fp8WPXJJY8QlTMHKpvGZhlBWUNGZiaVPhjibtw3VOxEwcCVGD9LZqy5Y4fA/132, createdBy=aaa55205975, createdName=zhaowujun567, createdTime=Sat Dec 18 22:39:46 CST 2021, time=2021-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188525, encodeId=dbce1188525b5, content=Awaiting AE Final Processing 这个状态一定会有马, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=44735423416, createdName=ms8000001716353498, createdTime=Thu Jan 27 09:28:05 CST 2022, time=2022-01-27, status=1, ipAttribution=)]
    2022-01-27 ms8000001716353498

    Awaiting AE Final Processing 这个状态一定会有马

    5

    展开5条回复
共182条页码: 1/19页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分